FDA ad watchdog slaps 2 pharmas with warning letters for promo emails, Google link
AstraZeneca puts a time limit on its COVID-19 ‘no-profit’ pledge: report
Moderna won’t enforce COVID-19 vaccine patents during pandemic
Gilead Sciences’ remdesivir cuts COVID-19 death risk in patients on low-flow oxygen
As Trump touts his ‘great’ COVID-19 drugs, the pharma cash flows to Biden, not him
